author-photo

Gen Kinoshita

Bristol-Myers Squibb

4

Papers

17

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan.

2019 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (7)
Elotuzumab Plus Lenalidomide/Dexamethasone (ELd) Vs Ld in Patients with Newly Diagnosed Multiple Myeloma: Phase 2, Randomized, Open-Label Study in Japan

2017 Blood
Show All
- Source
- Cite
- Save
Citations (4)
Elotuzumab with lenalidomide and dexamethasone for Japanese patients with relapsed/refractory multiple myeloma: phase 1 study

2017 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (6)